High Purity MK2206 Dihydrochloride Manufacturer & Supplier | Pharmaceutical Intermediate

We are a leading manufacturer and supplier of MK2206 Dihydrochloride (CAS 1032350-13-2), a critical pharmaceutical intermediate renowned for its high purity and potent inhibitory activity against Akt1, Akt2, and Akt3. Ideal for advanced research and drug development.

Get a Quote & Sample

Key Advantages of Our MK2206 Dihydrochloride

Potent and Selective Akt Inhibition

Our MK2206 Dihydrochloride offers potent and selective allosteric inhibition of Akt1, Akt2, and Akt3, with IC50 values in the nanomolar range, making it a highly effective tool for scientific research.

Exceptional Purity for Critical Applications

With a purity of ≥98% Min, our MK2206 Dihydrochloride meets the stringent requirements of pharmaceutical research and development, ensuring reliable and reproducible results for our clients.

Trusted Pharmaceutical Intermediate Manufacturer

As a dedicated manufacturer and supplier, we guarantee the quality and consistency of our MK2206 Dihydrochloride, providing peace of mind for your procurement needs.

Applications and Research Uses

Cancer Research & Therapy Development

MK2206 Dihydrochloride is extensively used in preclinical studies to investigate its role in cell cycle arrest, autophagy induction, and apoptosis, as well as its synergistic effects with chemotherapeutics for various cancer types.

Drug Discovery and Development

As a key pharmaceutical intermediate, it serves as a vital component in the synthesis and screening of new oncology drugs, contributing to advancements in pharmaceutical manufacturing.

Kinase Signaling Pathway Studies

Researchers utilize MK2206 Dihydrochloride to explore the intricacies of the PI3K/Akt signaling pathway and its downstream effects, crucial for understanding disease mechanisms.

Preclinical Drug Testing and Validation

This compound is essential for in vitro and in vivo validation studies, helping to assess the efficacy and potential of novel therapeutic agents.